awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
GraphQL
BETA
Graphs
1
Q28077289-7FCBE0C0-E4F4-428D-8D52-E4757B69968E
Q28077289-7FCBE0C0-E4F4-428D-8D52-E4757B69968E
BestRank
Statement
http://www.wikidata.org/entity/statement/Q28077289-7FCBE0C0-E4F4-428D-8D52-E4757B69968E
Retargeting the management of hypercholesterolemia - focus on evolocumab
P2860
Q28077289-7FCBE0C0-E4F4-428D-8D52-E4757B69968E
BestRank
Statement
http://www.wikidata.org/entity/statement/Q28077289-7FCBE0C0-E4F4-428D-8D52-E4757B69968E
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
8ec6ca6c9e6da87e6254383acfe58be5ea446e79
P2860
Efficacy and safety of longer-term administration of evolocumab (AMG 145) in patients with hypercholesterolemia: 52-week results from the Open-Label Study of Long-Term Evaluation Against LDL-C (OSLER) randomized trial.